Flagyl 400 mg Abbott Healthcare Pvt. Ltd.

£10.00

Flagyl 400 mg is a metronidazole-based antimicrobial compound from Abbott Healthcare, studied for its anaerobic bacterial inhibition mechanisms and protozoal effects in laboratory research.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Flagyl 400 mg Abbott Healthcare Pvt. Ltd.
Flagyl 400 mg Abbott Healthcare Pvt. Ltd.
£10.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview of Metronidazole 400mg

Flagyl 400 mg is a metronidazole formulation manufactured by Abbott Healthcare Pvt. Ltd., representing a well-established nitroimidazole antibiotic compound extensively studied in antimicrobial research. This pharmaceutical-grade preparation provides researchers with a standardised tool for investigating anaerobic bacterial inhibition mechanisms and protozoal activity modulation in controlled laboratory environments. The compound’s unique mechanism of action through DNA damage in anaerobic organisms makes it valuable for studying selective antimicrobial pathways. Research applications span from basic bacteriology studies to complex microbiome investigations, offering scientists at Stroid UK Shop access to pharmaceutical-quality materials for their experimental protocols.

Laboratory Research Applications

Metronidazole serves as a crucial research tool in multiple scientific disciplines, particularly in studies examining anaerobic bacterial resistance mechanisms and biofilm formation patterns. Laboratory investigations frequently examine the compound’s selective activity against Bacteroides species, Clostridium difficile, and various protozoal organisms including Trichomonas vaginalis and Entamoeba histolytica. Researchers studying antimicrobial resistance patterns utilise metronidazole as a reference compound when evaluating novel therapeutic strategies or combination treatments. The compound’s well-documented pharmacokinetic profile provides valuable comparative data for studies involving metronidazole and related antimicrobials. Additionally, investigations into microbiome modulation often incorporate metronidazole to study selective bacterial depletion effects, making it relevant for researchers working alongside SARM studies examining gut-muscle axis interactions or peptide research involving gastrointestinal barrier function.

Technical Specifications

Flagyl 400mg Research Specifications
Parameter Value
Active Ingredient Metronidazole 400mg
Manufacturer Abbott Healthcare Pvt. Ltd.
CAS Number 443-48-1
Molecular Formula C₆H₉N₃O₃
Molecular Weight 171.15 g/mol
Storage Requirements Room temperature, protect from light
Formulation Pharmaceutical tablet
Research Grade Pharmaceutical standard

Research Compliance Statement

Flagyl 400 mg Abbott Healthcare formulation is supplied exclusively for in-vitro laboratory research applications. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must adhere to institutional safety protocols when handling this compound and ensure appropriate laboratory containment measures. All studies should be conducted under proper ethical oversight with suitable controls and documentation. This product is restricted to qualified research institutions and licensed laboratories conducting legitimate scientific investigations into antimicrobial mechanisms, bacterial resistance patterns, or related microbiological studies.

Related